Abstract：
OBJECTIVE: This study aimed to determine the efficacy of gingivoperiosteoplasty (GPP) in preventing alveolar bone grafting (ABG) among children with cleft lip and palate (CLP).
METHODS: Retrospective university hospital single center study.
METHODS: Children with CLP treated with GPP from 2000-2015 were included. Those under eight years of age, without definitive conclusions regarding need for ABG or with incomplete data were excluded.
METHODS: Included patients were analyzed for demographics, cleft type, age at GPP, associated cleft surgery, use of nasoalveolar molding (NAM), indication for ABG, operating surgeon and presence of residual alveolar fistula. T-tests and Fisher\'s exact tests were utilized for statistical analysis.
METHODS: The need for ABG.
RESULTS: Of the 1682 children identified with CLP, 64 underwent GPP and met inclusion criteria. 78% of patients with CLP who underwent GPP were recommended for ABG. Those who received GPP at a younger age (P = .004) and at the time of initial cleft lip repair (P = .022) were less likely to be recommended for ABG. Patients with complete CLP were more likely to be recommended for ABG than patients with cleft lip and alveolus only (P = .015). The operating surgeon impacted the likelihood of ABG (P = .004). Patient gender, race, ethnicity, laterality, and NAM were not significantly associated with recommendation for ABG.
CONCLUSIONS: GPP does not preclude the need for ABG. Therefore, the success of ABG after GPP and maxillary growth restriction should be analyzed further to determine if GPP is a worthwhile adjunct to ABG in cleft care.
METHODS: Retrospective university hospital single center study.
METHODS: Children with CLP treated with GPP from 2000-2015 were included. Those under eight years of age, without definitive conclusions regarding need for ABG or with incomplete data were excluded.
METHODS: Included patients were analyzed for demographics, cleft type, age at GPP, associated cleft surgery, use of nasoalveolar molding (NAM), indication for ABG, operating surgeon and presence of residual alveolar fistula. T-tests and Fisher\'s exact tests were utilized for statistical analysis.
METHODS: The need for ABG.
RESULTS: Of the 1682 children identified with CLP, 64 underwent GPP and met inclusion criteria. 78% of patients with CLP who underwent GPP were recommended for ABG. Those who received GPP at a younger age (P = .004) and at the time of initial cleft lip repair (P = .022) were less likely to be recommended for ABG. Patients with complete CLP were more likely to be recommended for ABG than patients with cleft lip and alveolus only (P = .015). The operating surgeon impacted the likelihood of ABG (P = .004). Patient gender, race, ethnicity, laterality, and NAM were not significantly associated with recommendation for ABG.
CONCLUSIONS: GPP does not preclude the need for ABG. Therefore, the success of ABG after GPP and maxillary growth restriction should be analyzed further to determine if GPP is a worthwhile adjunct to ABG in cleft care.
摘要：
目的：本研究旨在确定在唇腭裂（CLP）儿童中，牙龈骨膜成形术（3GPP）预防牙槽骨移植（ABG）的功效。
方法：回顾性大学医院单中心研究。
方法：纳入了2000-2015年接受3GPP治疗的CLP儿童。八岁以下的人，没有关于需要ABG的明确结论或数据不完整的被排除.
方法：纳入患者的人口统计学分析，裂隙类型,年龄在3GPP，相关的裂隙手术，使用鼻肺泡成型（NAM），ABG的指示，手术外科医生和残余肺泡瘘的存在。采用T检验和Fisher精确检验进行统计分析。
方法：需要ABG。
结果：在确定为CLP的1682名儿童中，64人接受了3GPP，符合纳入标准。78％的CLP患者接受了GMP，建议接受ABG治疗。那些在较年轻的年龄（P=.004）和最初的唇裂修复（P=.022）时接受GMP的人不太可能被推荐用于ABG。与仅患有唇裂和肺泡的患者相比，患有完全CLP的患者更有可能被推荐用于ABG（P=0.015）。手术外科医生影响了ABG的可能性（P=.004）。患者性别,种族,种族,偏侧性,和NAM与ABG的推荐无显著相关性.
结论：不会排除ABG的需要。因此,应进一步分析在GMP和上颌骨生长受限后ABG的成功情况,以确定在裂隙治疗中,在ABG的辅助治疗中,GMP是否值得使用.
方法：回顾性大学医院单中心研究。
方法：纳入了2000-2015年接受3GPP治疗的CLP儿童。八岁以下的人，没有关于需要ABG的明确结论或数据不完整的被排除.
方法：纳入患者的人口统计学分析，裂隙类型,年龄在3GPP，相关的裂隙手术，使用鼻肺泡成型（NAM），ABG的指示，手术外科医生和残余肺泡瘘的存在。采用T检验和Fisher精确检验进行统计分析。
方法：需要ABG。
结果：在确定为CLP的1682名儿童中，64人接受了3GPP，符合纳入标准。78％的CLP患者接受了GMP，建议接受ABG治疗。那些在较年轻的年龄（P=.004）和最初的唇裂修复（P=.022）时接受GMP的人不太可能被推荐用于ABG。与仅患有唇裂和肺泡的患者相比，患有完全CLP的患者更有可能被推荐用于ABG（P=0.015）。手术外科医生影响了ABG的可能性（P=.004）。患者性别,种族,种族,偏侧性,和NAM与ABG的推荐无显著相关性.
结论：不会排除ABG的需要。因此,应进一步分析在GMP和上颌骨生长受限后ABG的成功情况,以确定在裂隙治疗中,在ABG的辅助治疗中,GMP是否值得使用.
